Cargando…

Antibody detection of translocations in Ewing sarcoma

The detection of chromosomal translocations has important implications in the diagnosis, prognosis and treatment of patients with cancer. Current approaches to translocation detection have significant shortcomings, including limited sensitivity and/or specificity, and difficulty in application to fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wen, Milash, Brett, Dalley, Brian, Smith, Richard, Zhou, Holly, Dutrow, Natalie, Cairns, Bradley R, Lessnick, Stephen L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2012
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443953/ https://www.ncbi.nlm.nih.gov/pubmed/22419563 http://dx.doi.org/10.1002/emmm.201200225

Ejemplares similares

Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016)

Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
por: Kowalewski, Ashley A., et al.
Publicado: (2011)

Molecular investigation of Ewing sarcoma: about detecting translocations
por: Blau, Olga
Publicado: (2012)

Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group
por: Kinnaman, Michael D., et al.
Publicado: (2020)

Microsatellites with Macro-Influence in Ewing Sarcoma
por: Monument, Michael J., et al.
Publicado: (2012)

Targeting Glutathione S-transferase M4 in Ewing sarcoma
por: Zhuo, Rupeng, et al.
Publicado: (2014)

Is There a Predisposition Gene for Ewing's Sarcoma?
por: Randall, R. L., et al.
Publicado: (2010)

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
por: Pishas, Kathleen I., et al.
Publicado: (2018)

Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
por: Patel, Priyal O., et al.
Publicado: (2019)

Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
por: Theisen, Emily R., et al.
Publicado: (2016)

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
por: Sankar, Savita, et al.
Publicado: (2012)

BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
por: Wiles, Elizabeth T., et al.
Publicado: (2013)

Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma
por: Weaver, Davis T., et al.
Publicado: (2021)

Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma
por: Johnson, Kirsten M., et al.
Publicado: (2017)

A Decade in Banking Ewing Sarcoma: A Report from the Children’s Oncology Group
por: Borinstein, Scott C., et al.
Publicado: (2013)

EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
por: Owen, Leah A., et al.
Publicado: (2008)

Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2020)

EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma
por: Fadul, John, et al.
Publicado: (2015)

Chromosomal translocations highlighted in Primitive Neuroectodermal Tumors (PNET) and Ewing sarcoma
por: Trancău, IO
Publicado: (2014)

Increased risk for other cancers in individuals with Ewing sarcoma and their relatives
por: Abbott, Diana, et al.
Publicado: (2019)

Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force
por: Bailey, Kelly, et al.
Publicado: (2019)

Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma
por: Scarborough, Jessica A., et al.
Publicado: (2020)

Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children’s Oncology Group
por: Shukla, Neerav, et al.
Publicado: (2013)

EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma
por: Showpnil, Iftekhar A, et al.
Publicado: (2022)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

A rare case of translocation (12;22) (p13;Q) in Ewing's sarcoma
por: Jahan, S. K. Kousar, et al.
Publicado: (2014)

Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma
por: Tokarsky, E. John, et al.
Publicado: (2022)

A monoclonal antibody specifically reactive with Ewing's sarcoma.
por: Hara, S., et al.
Publicado: (1989)

Latest developments in the pathobiology of Ewing sarcoma
por: Karlina, Irina, et al.
Publicado: (2022)

Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma
por: Stegmaier, Kimberly, et al.
Publicado: (2007)

C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells
por: Gardiner, Jamie D., et al.
Publicado: (2017)

The First European Interdisciplinary Ewing Sarcoma Research Summit
por: Kovar, Heinrich, et al.
Publicado: (2012)

Ewing's sarcoma of zygoma
por: Deshingkar, SA, et al.
Publicado: (2009)

Ewing's sarcoma of the mandible
por: Rao, B. H. Sripathi, et al.
Publicado: (2011)

Chemotherapy in Ewing’s sarcoma
por: Jain, Sandeep, et al.
Publicado: (2010)

The Biology of Ewing Sarcoma
por: Ross, Keir A., et al.
Publicado: (2013)

Ewing's Sarcoma of the Finger
por: Gökalp, Mehmet Ata, et al.
Publicado: (2014)

Ewing's Sarcoma of the Calcaneum
por: Sherif, P Ajmal, et al.
Publicado: (2017)

Paratesticular Ewing's sarcoma
por: Koshevarova, Victoria, et al.
Publicado: (2023)

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
por: Shulman, David S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c5gpfr0ngu5donuibumdcfba9r